<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02275637</url>
  </required_header>
  <id_info>
    <org_study_id>20140002277 del 27/05/2014</org_study_id>
    <nct_id>NCT02275637</nct_id>
  </id_info>
  <brief_title>Arrhythmias Detection in a Real World Population</brief_title>
  <acronym>RHYTHM DETECT</acronym>
  <official_title>Arrhythmias Detection in a Real World Population: the RHYTHM DETECT Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maurizio Eugenio Landolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Policlinico S. Matteo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective multicenter registry. Consecutive patients with indications of
      implant / replacement or upgrade of implantable cardioverter defibrillator (ICD) will be
      enrolled.

      The primary objective of the study is to determine the predictors of appropriate
      anti-tachycardia therapy (with shock) in a non-selected population of patients implanted with
      an ICD.

      Secondary objectives of the study are:

        -  the incidence of anti-tachycardia therapies;

        -  the predictors of inappropriate therapy and onset of arrhythmia burden;

        -  the adherence to the current guidelines in the Italian clinical practice;

        -  the predictors of heart failure (HF) onset and response to cardiac resynchronization
           therapy (CRT).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patients with ICD therapy (shock)</measure>
    <time_frame>24 months</time_frame>
    <description>Clinical or instrumental parameters that could predict the appropriate ICD therapies</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients with inappropriate shock therapy</measure>
    <time_frame>24 months</time_frame>
    <description>Clinical or instrumental parameters that could predict the inappropriate ICD therapies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of ICD therapies</measure>
    <time_frame>24 months</time_frame>
    <description>Number of patients with ICD therapies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first ICD therapy</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictors of onset and Atrial Fibrillation (AF) burden</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">4800</enrollment>
  <condition>Appropriate and Inappropriate Shock Therapy With ICD</condition>
  <condition>Arrhythmias Detection</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>implantable cardioverter defibrillator</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study requires patients implanted with a defibrillator that meet all
        inclusion/exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient implanted with a Subcutaneous (S)- Ventricular Chamber (VR)- Dual Chamber (DR)
             - or Cardiac Resynchronization Therapy (CRT) Defibrillator (this study will utilize
             all the market released CRT-D or VR/DR-ICD systems and leads)

          -  Patient is willing and able to sign an authorization to use and disclose health
             information or an Informed Consent

          -  Patient must be able to attend all required follow-up visits at the study center for
             at least 12 months

        Exclusion Criteria:

          -  Patient is participating in another clinical study that may have an impact on the
             study endpoints

          -  Women who are pregnant or plan to become pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maurizio Eugenio Landolina, MD</last_name>
    <phone>0382.501276</phone>
    <phone_ext>0039</phone_ext>
    <email>clinical-estimate@isis.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCC Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2014</study_first_submitted>
  <study_first_submitted_qc>October 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2014</study_first_posted>
  <last_update_submitted>October 23, 2014</last_update_submitted>
  <last_update_submitted_qc>October 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Policlinico S. Matteo</investigator_affiliation>
    <investigator_full_name>Maurizio Eugenio Landolina</investigator_full_name>
    <investigator_title>EP and Pacing Laboratory Director</investigator_title>
  </responsible_party>
  <keyword>Implantable Cardioverter-Defibrillators</keyword>
  <keyword>Ventricular Fibrillation</keyword>
  <keyword>ventricular Tachycardia</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

